Business Context and Reporting Period
This Form 8-K was filed by P10, Inc. on March 4, 2022, reporting an event occurring on February 28, 2022. The filing concerns executive compensation arrangements. The request metadata identifies Ridgepost Capital, Inc.; however, the filing itself identifies the registrant as P10, Inc., with Class A common stock trading under the symbol PX on the New York Stock Exchange.
Executive Compensation and Other Key Terms
- The Compensation Committee approved 2021 executive bonuses, 2022 base salaries, and the 2022 executive compensation plan.
- Chief Financial Officer Amanda Coussens received a discretionary cash bonus of $167,500 for 2021 performance.
- Ms. Coussens’s 2022 base salary increased from $325,000 to $400,000 annually.
- Base salaries for other executive officers were unchanged.
- The 2022 compensation plan provides for discretionary bonuses generally ranging from $200,000 to $400,000 per executive officer, payable in cash and/or restricted stock units by mutual agreement.
- Ms. Coussens received 8,385 restricted stock units, which vest on the one-year anniversary of the grant date.
- Ms. Coussens also received options to purchase 39,713 shares of Class A common stock, vesting on the fifth anniversary of the grant date.
Material Changes Versus the Prior Comparable Period
The principal disclosed change is the increase in the CFO’s annual base salary from $325,000 to $400,000. The filing also discloses the payment of 2021 discretionary bonuses and new equity awards under the 2022 compensation plan. No prior-period financial statements or comparable operating metrics are provided.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide revenue guidance, earnings guidance, operating outlook, liquidity information, debt information, cash-flow data, or management commentary on business risks. The disclosed compensation plan is discretionary, and the filing does not provide the exercise price, grant-date fair value, or other valuation terms for the options and RSUs.
Important Facts to Verify
- Confirm that P10, Inc. is the intended registrant, given the metadata reference to Ridgepost Capital, Inc.
- Verify the grant dates, option exercise price, expiration terms, and accounting treatment of the 39,713 stock options.
- Verify the vesting terms and total dilution impact of the 8,385 RSUs and other executive RSU grants.
- Review subsequent filings for additional executive compensation, amended employment agreements, or realized equity awards.
- Consult the company’s financial filings for financial performance, liquidity, debt, and cash-flow information not included in this Form 8-K.